Compare TALO & TNDM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TALO | TNDM |
|---|---|---|
| Founded | 2011 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Medical/Dental Instruments |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 1.5B |
| IPO Year | N/A | 2013 |
| Metric | TALO | TNDM |
|---|---|---|
| Price | $11.39 | $20.90 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 5 | 17 |
| Target Price | $14.30 | ★ $24.06 |
| AVG Volume (30 Days) | ★ 1.7M | 1.4M |
| Earning Date | 02-24-2026 | 02-19-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $1,872,554,000.00 | $1,007,001,000.00 |
| Revenue This Year | N/A | $8.59 |
| Revenue Next Year | N/A | $10.19 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 0.06 | ★ 17.87 |
| 52 Week Low | $6.23 | $9.98 |
| 52 Week High | $12.20 | $37.93 |
| Indicator | TALO | TNDM |
|---|---|---|
| Relative Strength Index (RSI) | 56.67 | 44.92 |
| Support Level | $10.33 | $20.29 |
| Resistance Level | $11.07 | $23.95 |
| Average True Range (ATR) | 0.36 | 0.99 |
| MACD | -0.00 | -0.33 |
| Stochastic Oscillator | 84.44 | 16.51 |
Talos Energy Inc is an independent oil and gas company predominantly involved in offshore exploration and production. The company has operations in the United States, the Gulf of Mexico, and offshore Mexico. The company's operating segments are; exploration and production of oil, natural gas and NGLs, and the CCS segment. The revenue is generated from the sale of oil, natural gas, and NGL quantities sold to purchasers.
Tandem Diabetes designs, manufactures, and markets durable insulin pumps for individuals with diabetes. The firm first entered this market in 2012 and has since introduced multiple generations of pumps leading to its current t:slim X2 device. The firm recently launched its smaller Mobi pump and continues to work on Tobi (a tubeless version of Mobi), and the Sigi tubeless patch pump. Nearly three-quarters of total revenue is derived from the US, with the remainder primarily from other developed nations. The pumps themselves generate just over half of total sales, and another one-third is from disposable infusion sets that need to be changed over every 2 to 3 days.